FiercePharma16h
Novartis falls short in legal effort to undo FDA approval of MSN's Entresto generic
As a host of generics circle the gates, Novartis has lost another bid to waylay MSN Pharmaceuticals’ copycat of the Swiss ...
FiercePharma21h
Viatris makes good on CEO's dealmaking promise with $25M licensing pact for Lexicon's heart med Inpefa
After Viatris’ CEO earlier this year promised to be “opportunistic” about future business development moves, the company is ...
FiercePharma19h
Tarsus taps actor Betsy Sodaro to embody a ‘mitey problem’ in 1st Xdemvy DTC TV ad
As the first treatment cleared by the FDA for Demodex blepharitis, an eye disease estimated to affect 25 million people in ...
FiercePharma20h
3rd time's the charm: AbbVie scores FDA nod for continuous Parkinson's disease therapy Vyalev
AbbVie made history in 2015 with its Parkinson’s disease infusion pump therapy Duopa, kicking off a trend of delivery system ...
FiercePharma20h
NIH study shows Bavarian Nordic's mpox shot elicits immune response in teens
With the clade 1 outbreak of mpox (formerly monkeypox) raging through the Congo and other countries in Central Africa, ...
FiercePharma21h
Canadian CDMO OmniaBio debuts new cell and gene therapy manufacturing facility
OmniaBio, a CDMO focused on cell and gene therapies, debuted a new manufacturing facility it claims to be the largest of its ...
FiercePharma20h
Eli Lilly shows how public restroom rarity affects ulcerative colitis patients
Eli Lilly has thrown its weight behind a cause beyond the traditional remit of pharma companies. | Eli Lilly has thrown its ...